Urologic Disorders and Diseases

BOSTON SCIENTIFIC INITIATES EUROPEAN LAUNCH OF SPACEOAR VUE™ HYDROGEL - 09 June 2021.

Boston Scientific Corporation (NYSE: BSX) today announced that it has initiated the European launch of SpaceOAR Vue™ Hydrogel...

Read more

Awareness of prostate health is alarmingly low in men over 50, a new survey commissioned by the European Association of Urology (EAU) has revealed, despite the fact that at the age of 60 and over, 40 percent of men suffer from an enlarged prostate. - 23 September 2019

Read more

Public awareness of urological conditions is alarmingly low throughout Europe. Results of a new international survey of more than 2,500 respondents in five European countries1 show that women know more about men’s health issues than men do, men have poor knowledge of key urological symptoms and don’t take early signs of potentially life-threatening urological conditions seriously. - September 24, 2018

Read more

National Institute for Health and Care Excellence Provides Positive Guidance for Use of Boston Scientific GreenLight XPS™ Laser Therapy System in the Treatment of BPH - June 14, 2016

Studies show that treatment is less costly and has lower hospital re-admissions.

Read more

Boston Scientific launches the LithoVueTM Single-Use Digital Flexible Ureteroscope in U.S. and Europe - Jan 12, 2016

Boston Scientific Corporation oday announced the U.S. and European launch of the LithoVueTM Single-Use Digital Flexible Ureteroscope for minimally invasive endoscopic procedures to diagnose)...

Read more

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com

Company Profile
Top